Basel has the biggest economic potential
Basel has the biggest economic potential in Europe, according to a new study from BAK Economics. The city on the bend of the Rhine ranked particularly well for competitiveness, while Geneva and Zurich also came in the top five.
BAK Economics has published a study on the economic potential of the 65 most important cities and 181 regions in Europe. Its findings revealed that Switzerland’s cities and regions are among the best in the Economic Potential Index.
Basel scooped 116 points to take the top spot. A key factor in its success was its pole position for competitiveness with 124 points. For attractiveness, the city on the bend of the Rhine took third place with 109 points, and for economic performance it ranked equally high with 114 points.
Geneva followed in second place with 115 points among the cities with the highest economic potential. London took third with 113 points and Zurich fourth with 112 points. The city on the Limmat was also named the most attractive of all 65 cities studied.
On a regional level, Basel was considered part of north-west Switzerland, which ranked fourth with 111 points. For competitiveness, it came second with 117 points, behind the Stockholm capital region with 122 points.
For best regions overall, Zurich was named third with 112 points behind London in second and Stockholm in first place. However, the Swiss regions have the greatest overall economic potential in Europe: the Lake Geneva region ranked sixth, Central Switzerland seventh, and Ticino eighth, with the Swiss regions occupying half of the top ten places.
Share this article
You might also be interested in
A research project is investigating the improvement in the condition of patients who have been hospitalized due to COVID-19. docdok.health based in Basel is contributing the smartphone app for the project.Read More
The Allschwil-based pharmaceutical company Idorsia receives a payment of 45 million US dollars as part of an agreement with Neurocrine Biosciences and shall also be entitled to claim milestone payments in future. Neurocrine has exercised a licensing option for a drug developed by Idorsia to treat epilepsy..Read More
Roche has received Emergency Use Authorization in the USA for an antibody test in connection with the novel coronavirus. The tests are already being distributed around the world. In May, production capacities are to already be scaled up to the high double-digit million area.Read More
Basel is valued as a location for company headquarters. In a rating from the fDi Intelligence platform of the Financial Times, Basel achieves eighth place in Europe. No other Swiss city does better.Read More
The investment and innovation promotion agency Basel Area Business & Innovation, previously known as BaselArea.swiss, can look back on a successful year in 2019. In this regard, positive developments in the healthtech sector and in Switzerland Innovation Park Basel Area stand out.Read More
The University Hospital Basel is the first Swiss hospital to have treated two Covid-19 patients with the plasma from a patient who has recovered from the virus, which means that they are receiving the appropriate antibodies. This method is a potential therapeutic option.Read More
The Basel-based Botnar Research Center for Child Health is providing capital in the amount of 15 million Swiss francs to its four partner institutions. In this way, the University of Basel should be in a position to advance research into dealing with the coronavirus outbreak.Read More